California Public Employees Retirement System Kronos Bio, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$20.08 - $29.02 $544,228 - $786,529	-27,103 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$27.0 - $32.48 $68,823 - $82,791	-2,549 Reduced 8.6%	27,103 $793,000
Q4 2020 Feb 02, 2021	BUY	$26.68 - $38.23 $791,115 - $1.13 Million	29,652 New	29,652 $886,000

Others Institutions Holding KRON

# of Institutions

Shares Held

19.8M

Call Options Held

9.3K

Put Options Held

100

Vida Ventures Advisors, LLC

2.77M
Shares

$2.49 Million
3.24% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.05M
Shares

$1.84 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.92M
Shares

$1.73 Million
0.0% of portfolio
Partners Capital Investment Group, LLP Boston, MA

1.61M
Shares

$1.45 Million
0.03% of portfolio
Alphabet Inc. Mountain View, CA

1.44M
Shares

$1.29 Million
0.1% of portfolio

View Full List

About Kronos Bio, Inc.

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $51.1M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

More about KRON

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account